Botanical species · safety record

Malpighia glabra

The EFSA Compendium of Botanicals holds 2 constituent measurements for Malpighia glabra. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Malpighia glabra L.

2Constituent measurements

0Safety records

1Cited sources

785Licensed products (Canada)

Also recorded as

Malpighia punicifolia L.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 785 licensed products naming Malpighia glabra as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Acerola berries
Acerola cherry
Berries
Berry
Berry (standardized extract)
Berry extract
Berry juice
Berry/Berries

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Furan derivatives	Fruit unspecified	Essential oil	2.1 Percent	GC-MS	No resolvable identifier
Furfural	Fruit unspecified	Essential oil	56.8 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Casadebaig, J., Pelissier, Y., Marion, C., Milhau, M., Bessiere, JM. Volatile constituents of fruits of Malpighia glabra L.. JOURNAL OF ESSENTIAL OIL RESEARCH, 2000, vol. 12, no. 6, p. 677-678.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature